Top compounds associated with response to EFNB1


Feature Type Standardized
Nominal ANOVA
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.054 0.1
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.064 0.1
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.093 0.1
mRNA GSK690693 GDSC1000 pan-cancer AAC 0.052 0.1
mRNA EX-527 GDSC1000 pan-cancer AAC -0.057 0.1
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.055 0.1
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.1
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.1
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.052 0.1
Download CSV